Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex: A Double-Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of Topically Applied Rapamycin

BACKGROUND AND OBJECTIVES: Facial angiofibromas are disfiguring facial lesions, present in up to 80% of patients with tuberous sclerosis complex. Recent elucidation of the complex cell signaling pathways that are disrupted in tuberous sclerosis indicates that rapamycin may be successful in alleviati...

Descripción completa

Detalles Bibliográficos
Autores principales: Koenig, Mary Kay, Hebert, Adelaide A., Roberson, Joan, Samuels, Joshua, Slopis, John, Woerner, Audrey, Northrup, Hope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585992/
https://www.ncbi.nlm.nih.gov/pubmed/22934754
http://dx.doi.org/10.2165/11634580-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585992/
https://www.ncbi.nlm.nih.gov/pubmed/22934754
http://dx.doi.org/10.2165/11634580-000000000-00000

Ejemplares similares